Literature DB >> 7864095

Modulation of Ca2+ influx in the ovine somatotroph by growth hormone-releasing factor.

C Chen1, I J Clarke.   

Abstract

Voltage-gated Ca2+ currents were recorded using the nystatin-perforated whole cell recording configuration on the ovine somatotrophs. With the use of Ca(2+)-tetraethylammonium chloride bath solution and Cs+ electrode solution, two types of Ca2+ currents were obtained with a predominant long-lasting (L) current blocked by nifedipine. A transient (T) current was isolated in the presence of nifedipine (3 microM) and was not blocked by omega-conotoxin (5 microM), but diminished to 47 +/- 5% of control by Ni2+ (0.3 mM) or to 52 +/- 10% of control by amiloride (0.5 mM). The nifedipine-blockable L-type current was not affected by omega-conotoxin (5 microM); it was, however, attenuated to 80 +/- 4% of control by Ni2+ (0.3 mM) and to 48 +/- 6% of control by amiloride (0.5 nM). Cd2+ (1 mM) totally prevented both T and L currents. Application of growth hormone-releasing factor (GRF, 10 nM) reversibly increased the amplitude of both Ca2+ currents without modifying their kinetic properties. The effect of GRF was observed approximately 30 s after application, peaked (142 +/- 11% of control, n = 5) rapidly, and lasted > 10 min if GRF treatment was continuous. Intracellular Ca2+ concentration ([Ca2+]i) was increased by GRF (10 nM) within seconds, reaching a peak within 30 s and lasting > 250 s. Blockade of Ca2+ channels (Cd2+, 1 mM) or the use of Ca(2+)-free solution reduced basal [Ca2+]i and significantly (P < 0.05) diminished the effect of GRF on [Ca2+]i.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7864095     DOI: 10.1152/ajpendo.1995.268.2.E204

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  11 in total

1.  Growth hormone-releasing hormone triggers pacemaker activity and persistent Ca2+ oscillations in rat somatotrophs.

Authors:  R Kwiecien; V Tseeb; A Kurchikov; C Kordon; C Hammond
Journal:  J Physiol       Date:  1997-03-15       Impact factor: 5.182

2.  The expression and role of hyperpolarization-activated and cyclic nucleotide-gated channels in endocrine anterior pituitary cells.

Authors:  Karla Kretschmannova; Marek Kucka; Arturo E Gonzalez-Iglesias; Stanko S Stojilkovic
Journal:  Mol Endocrinol       Date:  2011-12-01

Review 3.  Ion channels and signaling in the pituitary gland.

Authors:  Stanko S Stojilkovic; Joël Tabak; Richard Bertram
Journal:  Endocr Rev       Date:  2010-07-21       Impact factor: 19.871

4.  Effect of gsp oncogene on somatostatin receptor subtype 1 and 2 mRNA levels in GHRH-responsive GH3 cells.

Authors:  Eunhee Kim; Sookjin Sohn; Mina Lee; Cheolyoung Park; Jeechang Jung; Seungjoon Park
Journal:  Pituitary       Date:  2005       Impact factor: 4.107

5.  G(o)-2 protein mediates the reduction in Ca2+ currents by somatostatin in cultured ovine somatotrophs.

Authors:  C Chen; I J Clarke
Journal:  J Physiol       Date:  1996-02-15       Impact factor: 5.182

6.  Human GHRH reduces voltage-gated K+ currents via a non-cAMP-dependent but PKC-mediated pathway in human GH adenoma cells.

Authors:  R Xu; S G Roh; K Loneragan; M Pullar; C Chen
Journal:  J Physiol       Date:  1999-11-01       Impact factor: 5.182

Review 7.  Molecular mechanisms of pituitary endocrine cell calcium handling.

Authors:  Stanko S Stojilkovic
Journal:  Cell Calcium       Date:  2011-12-03       Impact factor: 6.817

8.  Role of nonselective cation channels in spontaneous and protein kinase A-stimulated calcium signaling in pituitary cells.

Authors:  Melanija Tomić; Marek Kucka; Karla Kretschmannova; Shuo Li; Maria Nesterova; Constantine A Stratakis; Stanko S Stojilkovic
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-05-17       Impact factor: 4.310

Review 9.  Dependence of the excitability of pituitary cells on cyclic nucleotides.

Authors:  S S Stojilkovic; K Kretschmannova; M Tomić; C A Stratakis
Journal:  J Neuroendocrinol       Date:  2012-09       Impact factor: 3.627

10.  The in vitro regulation of growth hormone secretion by orexins.

Authors:  Chen Chen; Ruwei Xu
Journal:  Endocrine       Date:  2003-10       Impact factor: 3.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.